Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy

European Urology
Alberto BrigantiPierre I Karakiewicz

Abstract

Our goal was to develop and internally validate a nomogram for prediction of lymph node invasion (LNI) in patients with clinically localized prostate cancer undergoing extended pelvic lymphadenectomy (ePLND). 602 consecutive patients (mean age 65.8 years) underwent an ePLND, where 10 or more nodes were removed. PSA was 1.1-49.9 (median 7.2). Clinical stages were: T1c in 55.6%, T2 in 41.4% and T3 in 3%. Biopsy Gleason sums were: 6 or less in 66%, 7 in 25.4%, 8-10 in 8.6%. Multivariate logistic regression models tested the association between all of the above predictors and LNI. Regression-based coefficients were used to develop a nomogram predicting LNI and 200 bootstrap resamples were used for internal validation. Mean number of lymph nodes removed was 17.1 (range 10-40). LNI was detected in 66 patients (11.0%). Univariate predictive accuracy for total PSA, clinical stage and biopsy Gleason sum was 63%, 58% and 73%, respectively. A nomogram based on clinical stage, PSA and Biopsy Gleason sum demonstrated bootstrap-corrected predictive accuracy of 76%. A nomogram based on pre-treatment PSA, clinical stage and biopsy Gleason sum can highly accurately predict LNI at ePLND.

References

Jul 20, 2002·The Journal of Urology·Pia BaderUrs E Studer
Nov 16, 2004·The Journal of Urology·Mohamad E AllafPatrick C Walsh
Jul 28, 2005·European Urology·G AusUNKNOWN European Association of Urology

❮ Previous
Next ❯

Citations

Dec 18, 2008·Der Urologe. Ausg. A·T SchlommM Graefen
Mar 20, 2010·Der Urologe. Ausg. A·H IsbarnM Graefen
Jul 11, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Cristina NanniStefano Fanti
Mar 23, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Giampiero GiovacchiniCristina Messa
Mar 3, 2007·World Journal of Urology·Felix K-H ChunMarkus Graefen
May 11, 2011·International Journal of Clinical Oncology·Jun Miki, Shin Egawa
Feb 9, 2008·Nature Clinical Practice. Urology·Pierre I Karakiewicz, Georg C Hutterer
May 21, 2008·Prostate Cancer and Prostatic Diseases·B N BreyerC J Kane
Apr 25, 2012·Journal of Endourology·Henk G van der PoelErik van Muilekom
Jul 18, 2012·Journal of Endourology·Henk G van der PoelErik van Muilekom
Dec 17, 2009·Future Oncology·Shahrokh F ShariatPeter T Scardino
Jul 4, 2008·Acta chirurgica Iugoslavica·J Bogdanovic, J Djozic
Jan 27, 2007·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Nebojsa JeremićVinka Maletić-Vuković
Sep 19, 2007·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Snezana CerovićVinka Maletić-Vukotić
Mar 9, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mohammed HaseebuddinTom R Miller
Dec 31, 2010·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·D Robert Siemens
Dec 7, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·L SalomonUNKNOWN Oncology Committee of the French Association of Urology (CCAFU)
May 31, 2008·European Urology·Alberto BrigantiFrancesco Montorsi
Jan 16, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Gijs H KleinJanFijs W B van Leeuwen
Sep 1, 2012·International Journal of Radiation Oncology, Biology, Physics·Alberto BrigantiCesare Cozzarini
Nov 1, 2010·Insights Into Imaging·Egesta LopciStefano Fanti
Nov 3, 2011·The Urologic Clinics of North America·Jeffrey C La Rochelle, Christopher L Amling
Nov 3, 2011·The Urologic Clinics of North America·A Ari Hakimi, Reza Ghavamian
Apr 13, 2011·International Journal of Radiation Oncology, Biology, Physics·Lisa K Morikawa, Mack Roach
Mar 1, 2011·European Urology·R Jeffrey Karnes
Dec 18, 2010·International Journal of Radiation Oncology, Biology, Physics·Jarrod B AdkisonMark A Ritter
Aug 31, 2010·European Journal of Radiology·Chiara FuccioStefano Fanti
Sep 14, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·J LarocheF Bladou
Oct 20, 2009·The Journal of Urology·Pierre I KarakiewiczJean-Jacques Patard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.